Most powerful obesity drug yet: People lost up to 25% of weight in trial

Retatrutide is a triple-hormone obesity drug simulating GLP-1, GIP, and glucagon.
Ars Technica reported this story. Read the full report on arstechnica.com →

Retatrutide is a triple-hormone obesity drug simulating GLP-1, GIP, and glucagon.
Ars Technica reported this story. Read the full report on arstechnica.com →
Leave a Reply